TGFB1 and Alzheimer disease: Neuroinflammation in AD involves mediators such as IL-1β, IL-6, TNF-α and TGF-β that are upregulated in patients compared to healthy individuals [12–15], as well as in the 5xFAD transgenic mouse model of AD (Tg) [16,17].